Home/Filings/4/0001640455-20-000068
4//SEC Filing

Diaz Luis 4

Accession 0001640455-20-000068

CIK 0001640455other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 7:28 PM ET

Size

5.5 KB

Accession

0001640455-20-000068

Insider Transaction Report

Form 4
Period: 2020-06-26
Diaz Luis
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-26+13,55013,550 total
    Exercise: $7.58Exp: 2030-06-26Common Stock (13,550 underlying)
Footnotes (1)
  • [F1]The option will vest in equal quarterly installments during the four quarters following the grant date, provided that if the Issuer's 2021 annual meeting of stockholders occurs before the one-year anniversary of the grant date, the unvested portion of the option will vest as of the date of such annual meeting, subject in each case to the Reporting Person's continued service on the Issuer's board of directors.

Issuer

Jounce Therapeutics, Inc.

CIK 0001640455

Entity typeother

Related Parties

1
  • filerCIK 0001720081

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 7:28 PM ET
Size
5.5 KB